President Trump signed an executive order on Saturday to make some psychedelic drugs more available to treat mental health ...
By targeting underlying synovitis, the novel intra-articular liraglutide formulation 4P004 aims to bridge the gap between transient symptom relief and disease modification in knee OA.
President Trump signed an executive order to fast-track the study of using psychedelic drugs to treat Americans – especially ...
Enolen's fast track designation by the FDA aims to expedite its development for localized prostate cancer treatment, addressing unmet medical needs. The localized delivery technology targets ...
President Donald Trump has ordered the reclassification of medical marijuana from Schedule I to Schedule III and directed agencies to fast-track psychedelic drug research. The FDA will compress review ...
The FDA has granted Regenerative Medicine Advanced Therapy designation to NouvNeu001, a cell therapy for Parkinson’s disease. NouvNeu001, developed by iRegene, is the first allogeneic cell therapy ...
FDA fast tracked ZW191 for platinum-resistant ovarian cancer, aiming to speed development of a potential new option for patients with limited treatments. The U.S. Food and Drug Administration (FDA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results